Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00143065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Small Lymphocytic
Lymphocytic Leukemia, Chronic

Interventions

DRUG: Fludarabine
DRUG: Rituximab
DRUG: Alemtuzumab

Sponsor

Ohio State University Comprehensive Cancer Center